Circle of Care is now offering specialized support services for men with prostate cancer. Services include a support group ...

The nonoperative regimen led to a 2-year total mesorectal excision (TME)-free survival of 57% in 63 evaluable patients, and a 2-year progression-free survival (PFS) of 84%. Almost all patients ...

After a stage 3b rectal cancer diagnosis, one patient endured radiation, chemotherapy, surgery, and complications, relying on resilience, advocacy and support.

A shorter radiation course improved quality of life among men with intermediate-risk, localized prostate cancer, according to ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

People with mild to moderate wear-and-tear knee arthritis felt less pain and had better mobility after low-dose radiation ...

The Chinorec trial reveals that combining Yervoy and Opdivo with chemoradiotherapy is safe for rectal cancer, though response rates remain unchanged.

Trop-2-targeted datopotamab deruxtecan (Datroway) significantly improved survival versus chemotherapy as initial treatment ...

Colorectal cancer is the second most common cause of cancer-related death in women and the third most common in men. Since the 1980s, the incidence of colorectal cancer in individuals aged 50 and ...

In the last decade, more than a dozen types of cancer have risen among people under 50. Scientists don’t have all of the ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

An eminent oncologist, cancer researcher, and cancer center director is promoting a study that seems to show—but, when ...